CRISPR and CRISPR-associated (Cas) Genes Market To Develop Strongly And Cross USD 3.73 billion By 2032
The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1.56 Bn in 2021 and is poised to grow at a CAGR of 16.67% to reach USD 3.73 Bn by the year 2032.
The COVID-19 Pandemic is expected to positively impact the market because of increased demand for COVID-19 diagnosis tests. Sherlock Biosciences (USA) announced that it was granted Emergency Use Authorization by the United States Food and Drug Administration in May 2020 for its Sherlock SARS CoV-2 tool, which is used to detect COVID-19. The SherlockCRISPR SARS-2 Kit could give results in about an hour. This was considerably faster than the average time taken to test the virus. In December 2020, researchers at the University of California San Francisco, UC Berkeley, and the Gladstone Institutes announced a collaboration to produce a new CRISPR-based test for COVID-19. It uses a simple smartphone camera to turn it into a microscope that can detect coronavirus genetic material. CRISPR and CRISPR-associated genes (Cass) Genes will see these initiatives positively impact the market.
To know about more drivers and challenges – Download a PDF sample@ https://market.us/report/crispr-and-crispr-associated-genes-market/request-sample/
CRISPR has seen a significant increase in its use in genome editing and related biotechnological research. CRISPR has seen a rapid rise in popularity over the last few years. Its role in adaptive immunity was discovered in bacteria, and it has been developed into an effective and accessible tool in gene editing. CRISPR technology enables advances in genome engineering across biotechnology, medicine, and agriculture. This has enabled scientists to conduct their research using faster and more effective genome editing in all three fields. CRISPR technology continues to be in demand. This is due to easy access to quick, inexpensive vectors and the next-generation tools available through the Addgene non-profit repository. According to “The CRISPR Journal,” Addgene distributed more CRISPR technology to 3,400 laboratories globally in January 2018, and over 330 labs created more than 6,300 CRISPR genes. These plasmids were then added to Addgene’s growing collection. Companies can expect to take positive steps and engage in collaborative efforts.
Drivers:
The pharmaceutical and biopharmaceutical sectors are driving the market growth.
CRISPR is becoming more popular, as is the prevalence of genetic and chronic disorders.
The increasing use of gene editing technology will also boost the market growth.
Restraints:
Due to intense competition and the high cost of the study, the market will be limited.
Recent Developments
Editas Medicine declared in August 2020 that it had regained exclusive rights to several experimental CRISPR-based gene editing therapies for eye diseases, which AbbVie Inc. had licensed.
Intellia Therapeutics, Inc. released preclinical information in support of NTLA 5001, the company’s Wilms’ Tumor 1-directed TCR/T cell therapy candidate for treating acute myeloid leukemia.
Key Market Segments
Type
- Genome Editing
- Genetic engineering
- GRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
Application
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
Key Market Players included in the report:
- Thermo Fisher Scientific
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics
- Cellectis
- Horizon Discovery Plc
- Sigma Aldrich
- Precision Biosciences
- Genscript
- Sangamo Biosciences
- Lonza Group Limited
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
About Market.us
Market.US (Powered by Prudour Private Limited) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm.
Contact Details:
Global Business Development Team – Market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)
Email: [email protected]
I am author, tech blogger, and digital marketing expert who has been writing since 4.5 years. I am a computer engineer by profession. My passion is to think of new ways that help websites improve their SEO in a healthy way. I enjoys sharing knowledge and information on multiple subjects with the aim of creating online visibility and sharing thoughts. Aside from that, my hobbies are reading books, listening to music and watching sports.
